A. Jaques

发表

Coverage of the Victorian newborn screening programme in 2003: A retrospective population study

J. Pitt, J. Halliday, V. Collins, 2008, Journal of paediatrics and child health.

Follow up and evaluation of the Victorian first‐trimester combined screening programme for Down syndrome and trisomy 18

L. Sheffield, J. Halliday, L. Bonacquisto, 2007, BJOG : an international journal of obstetrics and gynaecology.

Do women know that prenatal testing detects fetuses with Down syndrome?

J. Halliday, A. Jaques, R. Bell, 2004, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

People who influence women's decisions and preferred sources of information about prenatal testing for birth defects

L. Watson, J. Halliday, A. Jaques, 2004, The Australian & New Zealand journal of obstetrics & gynaecology.

Uptake of prenatal diagnostic testing and the effectiveness of prenatal screening for Down syndrome

E. Muggli, D. Amor, J. Halliday, 2010, Prenatal diagnosis.

“It gives them more options”: preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare

S. Metcalfe, A. Archibald, J. Cohen, 2016, Journal of Community Genetics.

Adverse obstetric and perinatal outcomes in subfertile women conceiving without assisted reproductive technologies.

O. Ukoumunne, D. Amor, J. Halliday, 2010, Fertility and sterility.

Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia.

J. Halliday, H. Baker, D. Healy, 2010, Human reproduction.

Increased risk of blastogenesis birth defects, arising in the first 4 weeks of pregnancy, after assisted reproductive technologies.

O. Ukoumunne, D. Amor, J. Halliday, 2010, Human reproduction.

Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.

D. Amor, J. Halliday, H. Baker, 2009, Human reproduction.

Early pregnancy Increased risk of blastogenesis birth defects , arising in the first 4 weeks of pregnancy , after assisted reproductive technologies

O. Ukoumunne, D. Amor, J. Halliday, 2009 .

Early pregnancy Pregnancies conceived using assisted reproductive technologies ( ART ) have low levels of pregnancy-associated plasma protein-A ( PAPPA ) leading to a high rate of false-positive results in first trimester screening for Down syndrome

D. Amor, J. Halliday, H. Baker, 2009 .

Preterm birth, ovarian endometriomata, and assisted reproduction technologies.

G. Baker, J. Halliday, D. Healy, 2009, Fertility and sterility.

Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects

J. Halliday, V. Collins, K. Haynes, 2006, Journal of medical screening.

Using population-based data to predict the impact of introducing noninvasive prenatal diagnosis for Down syndrome

E. Muggli, D. Amor, J. Halliday, 2010, Genetics in Medicine.

Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening

J. Emery, S. Metcalfe, O. Ukoumunne, 2015, Health expectations : an international journal of public participation in health care and health policy.

“It's about having the choice”: Stakeholder perceptions of population‐based genetic carrier screening for fragile X syndrome

S. Metcalfe, A. Archibald, J. Cohen, 2013, American journal of medical genetics. Part A.

“It's something I need to consider”: Decisions about carrier screening for fragile X syndrome in a population of non‐pregnant women

S. Metcalfe, A. Archibald, V. Collins, 2009, American journal of medical genetics. Part A.

Cerebral palsy and assisted reproductive technologies: a case–control study

D. Reddihough, J. Halliday, S. Reid, 2010, Developmental medicine and child neurology.

Informed choice in women attending private clinics to undergo first‐trimester screening for Down syndrome

J. Halliday, L. Sheffield, A. Jaques, 2005, Prenatal diagnosis.

Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancy

L. Sheffield, A. Jaques, 2003, Prenatal diagnosis.

“It gives them more options”: preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare

S. Metcalfe, A. Archibald, J. Cohen, 2016, Journal of Community Genetics.

“It's something I need to consider”: Decisions about carrier screening for fragile X syndrome in a population of non‐pregnant women

S. Metcalfe, A. Archibald, V. Collins, 2009, American journal of medical genetics. Part A.

Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia.

H. Baker, D. Rushford, C. Garrett, 2010, Human reproduction.